EP Patent

EP3071567B1 — Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase

Assigned to Actelion Pharmaceuticals Ltd · Expires 2017-09-06 · 9y expired

What this patent protects

Patent listed against telotristat-etiprate.

Drugs covered by this patent

telotristat-etiprate (TELOTRISTAT ETIPRATE)

Patent Metadata

Patent number: EP3071567B1
Jurisdiction: EP
Classification: —
Expires: 2017-09-06
Drug substance claim: No
Drug product claim: No
Assignee: Actelion Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.